Business Wire

Airship Journeys Powers Massive Conversion Gains for Brands Across the Globe

29.10.2020 11:30:00 EET | Business Wire | Press release

Share

Customer engagement company Airship today detailed the amazing success three brand marketers have achieved using Airship Journeys to more quickly and easily improve the business impact of cross-channel customer journeys. The customer journeys these marketers have optimized have driven double- and even triple-digit percentage performance improvements over baselines established by control groups.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029005340/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Airship Journeys enables an at-a-glance understanding of how cross-channel journeys are performing against business goals, trending performance lifts against control group baselines to direct optimization efforts and maximize business value. (Graphic: Business Wire)

Airship Journeys combines everything marketers need to create, evaluate, test and optimize cross-channel customer engagement journeys in a single, intuitive visual UI. Only Airship Journeys allows marketers to zoom in from glanceable, color-coded visualizations of journey performance against business goals and baselines, to view and optimize any underlying message with A/B testing.

As the largest professional social network and digital distribution platform for musicians and other creative types, Vampr has created numerous journeys since selecting Airship in August 2020. A recently launched reactivation journey targets app users who have been inactive for five days with a series of three push notifications and a final email within two weeks, and has been found to reactivate users at a 277 percent higher rate than those in the control group.

“My goal is to drive critical business KPIs by getting users to complete their profiles, connect with nearby creatives, add their original songs and videos, and much more — 90 percent of the time I’m using Airship Journeys to optimize these user experiences,” said Jessy Trengove, head of insights, Vampr. “By being able to easily see journey performance against baseline metrics and control groups, I’m more easily able to achieve the goals that make a real difference to the business.”

On Black Friday, J. C. Penney Company, Inc. used Airship Journeys to transform a one-message cart abandonment automation into a two-message journey and found significant lift in completed purchases. This cart abandonment journey now shows an all-time increase of 40 percent higher purchase completion rates over the control group baseline. JCP reactivation messages spread across three separate automations are now being combined into a single journey, enabling a goal-based view of business impact rather than trying to draw conclusions by comparing each message’s engagement metrics.

“With Airship Journeys, we can see where each customer comes into and progresses through each phase and can more easily A/B test any message in the journey to optimize timing, triggers, copy and content,” said Haley Welmon, owned media specialist, JCPenney. “Airship Journeys control groups and baselines help us make decisions and increase revenue more quickly, so we can maximize our success and ensure that what we think is the best experience for the customer, actually is.”

In hospitality, in their mobile app, Radisson Hotel Group has created a cart abandonment journey series spanning three messages over four days — the first of which guarantees the room’s rate — driving an 11 percent lift in completed reservations over the control group.

Tune in to the webinar, “Creating Extraordinary Customer Journeys with a Culture of Experimentation,” live Thursday, October 29 at 10am PDT / 1pm EDT / 5pm GMT / 6pm CET (recording available to registrants), and learn how to gain advantage by experimenting, testing and optimizing critical cross-channel customer journeys.

“It’s so gratifying to see how quickly brands have realized substantial business gains due to the powerful way we’ve reinvented cross-channel journeys for the mobile era,” said Brett Caine, CEO and president, Airship. “Engaging customers with in-the-moment relevancy across digital channels has never been more important, and small improvements can drive big results. Airship Journeys brings breakthrough simplicity to the entire process and speeds insights-to-optimization to accelerate revenue growth.”

Recently, Airship was named a Leader in “The Forrester Wave™: Mobile Engagement Automation, Q3 2020,” receiving the highest score in the Strategy category (tied) and the second highest score in the Current Offering category.

About Airship

Thousands of the world’s leading brands rely on Airship to spark closer connections with their customers through highly contextual and relevant interactions. Only Airship’s Customer Engagement Platform takes a mobile-first, data-led approach that enables brands to focus on individuals and their needs, not which marketing channels to use. Airship makes it much simpler and more effective to grow customer lifetime value in the omnichannel era.

With trillions of interactions intelligently orchestrated across mobile apps, mobile wallet, SMS, websites, and email, Airship optimizes the entire customer journey across all digital touchpoints at scale.

For more information, visit www.airship.com, read our blog or follow us on Twitter, LinkedIn and Facebook.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

North America:
Danielle Stickler
Mission North for Airship
+1 415-749-9124
airship@missionnorth.com

Corey Gault
Airship
+1 503-206-9164
corey@airship.com

UK:
Ana Williams
Airship
+44 (0)20 3405 5160
Ana.Williams@airship.com

France:
Samira Chakkaf Andalouci
Pepper Menthe Communication for Airship
07 86 11 14 52
Samira@peppermenthe.com

Germany:
Kerstin Bauer
Koschade PR
+49 89 55066850
info@koschadepr.de

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 12:18:00 EEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 11:11:00 EEST | Press release

Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye